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developing infections
ABSTRACT
Objective: To investigate early changes in leukocyte subsets and autonomic function as predic-
tors of the development of poststroke infections.
Methods: We assessed the time course of leukocyte subsets in the blood of 59 patients with
acute ischemic stroke. We divided the patients into 2 groups: those who developed infections
during the first 7 days after stroke onset and those who did not. We measured urinary norepi-
nephrine and epinephrine concentrations and pulse rate variability indices within 24 hours of
admission.
Results: We found that the number of circulating natural killer (NK) cells within the first hours
after stroke was higher in stroke patients who developed infections (mean 435 cells/mL; 95%
confidence interval [CI] 321–588) than in stroke patients who did not develop infections (mean
236 cells/mL; 95% CI 186–300; p5 0.001). This was followed by a decrease in all lymphocyte
subsets from admission to day 1, varying between 22% and 40%, which was not seen in
patients without poststroke infection (mean increase varied between 2% and 23%; all p ,
0.005). In the group that developed infections, pulse rate variability revealed a decreased high
frequency component. These findings all remained significant after adjustment for age and
stroke volume.
Conclusions: High circulating NK cell count within the first hours after ischemic stroke onset fol-
lowed by a drop in all lymphocyte subsets identified patients who developed infections and may
be caused by a sympathovagal imbalance with sympathetic overweight. These findings need to be
validated in larger studies. Neurol Neuroimmunol Neuroinflamm 2015;2:e71; doi: 10.1212/
NXI.0000000000000071
GLOSSARY
ANCOVA5 analysis of covariance;CRP5C-reactive protein;DWI5 diffusion-weighted imaging;HF5 high frequency range;
HRV 5 heart rate variability; IQR 5 interquartile range; LF 5 low frequency range; NK 5 natural killer; NKT 5 natural killer T
cells; PRV 5 pulse rate variability; PSI 5 poststroke infections; RMSSD 5 root mean square differences of successive RR
intervals; SDNN 5 SD of a series of RR intervals; SID 5 stroke-induced immunodepression.
Early infections, especially pneumonia and urinary tract infections, occur in 30% of stroke
patients and are associated with worse functional outcome, increased mortality, longer hos-
pitalization, and increased costs for medical care.1 This increased vulnerability to infections
may be at least partially explained by stroke-induced immunodepression (SID), which is
characterized mainly by lymphocytopenia.2–5 The underlying mechanism of SID remains
uncertain.
An early biomarker predicting poststroke infections (PSI) would aid in selecting patients
for prophylactic therapy. A feasibility study found that heart rate variability (HRV) indices
suggestive of a sympathovagal imbalance with parasympathetic overweight obtained within
48 hours after ischemic stroke predicted the development of subacute PSI.6 Other studies
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suggested an association between increased
sympathetic activity and PSI.3,7 We com-
pared the number of circulating leukocyte
subsets at different time points and parame-
ters of autonomic function in ischemic stroke
patients who developed infections during the
first 7 days after stroke onset and those who
did not.
METHODS Subjects. Sixty-six patients with acute ischemic
stroke admitted within 8 hours after symptom onset or within
4 hours after wake-up symptoms were prospectively included.
Ischemic stroke was diagnosed clinically, confirmed by cerebral
CT on admission, and followed by brain MRI. We excluded 2
patients with a stroke mimic and 5 patients with an infection
during the last week before stroke onset. Stroke severity was
measured by certified neurologists using the NIH Stroke Scale
on admission and on days 1 and 3. Poor functional outcome
was defined as a modified Rankin Scale score of .2 at 3
months. Strokes were classified etiologically following the
TOAST criteria.8 All patients were treated in the stroke unit
according to the recommendations of the European Stroke
Initiative.9
Standard protocol approvals, registrations, and patient
consents. The protocol was approved by the local ethics com-
mittee. All patients or their next of kin signed a written informed
consent.
Catecholamines. A 24-hour urine collection was started upon
admission to the emergency department. Norepinephrine and
epinephrine concentrations were measured using high-
performance liquid chromatography with electrochemical
detection. Detection limit was 0.05 mg/L.
Pulse rate variability analysis. Pulse rate variability (PRV)
indices were calculated from 5-minutes beat-to-beat blood
pressure recordings obtained via a Nexfin monitor (BMEYE
B.V., Amsterdam, the Netherlands) within the first 24 hours
after stroke onset. Patients with atrial fibrillation were excluded.
The Nexfin device measures noninvasive beat-to-beat arterial
blood pressure by the volume clamp method through
plethysmography using an inflatable finger cuff. PRV derived
from noninvasive blood pressure waveforms corresponds
sufficiently with traditional HRV derived from ECG in subjects
at rest.10 PRV was calculated using Kubios software (University
of Eastern Finland, Kuopio, Finland). We calculated the most
commonly used time domain and spectrum domain HRV
parameters to estimate PRV on 5-minute recordings, which
were SD of a series of RR intervals (SDNN), root mean square
differences of successive RR intervals (RMSSD), high frequency
range (HF), low frequency range (LF), and LF/HF. SDNN
estimates overall HRV. RMSSD evaluates short-term HRV,
which reflects parasympathetic activity. HF is considered an
index of parasympathetic activity, whereas LF reflects a mixture
of baroreceptor-mediated parasympathetic and sympathetic
activity. The LF/HF ratio is used as an index of sympathovagal
balance.11
Stroke localization and size. Brain MRI was performed
between day 3 and day 5 on a 1.5-tesla MRI scanner
(Philips, Eindhoven, the Netherlands) and included T1, T2,
fluid-attenuated inversion recovery, and diffusion-weighted
imaging (DWI) sequences. Infarction volume was calculated
on the DWI sequences with dedicated software from Olea
Medical (Marseille, France). The operator was blinded to the
clinical data.
Poststroke infection. Infections were diagnosed during the first
7 days after stroke onset using the modified criteria of the US
Centers for Disease Control and Prevention. Pneumonia was
diagnosed when at least one of the former and one of the latter
criteria were fulfilled: (1) abnormal respiratory examination, pul-
monary infiltrates on chest x-rays; (2) productive cough with
purulent sputum, microbiological cultures from lower respiratory
tract or blood cultures, leukocytosis, elevation of C-reactive pro-
tein (CRP). Diagnosis of urinary tract infection was made when
at least 2 of the following criteria were present: fever (.38°C),
urine sample positive for nitrite, leukocyturia, and significant
bacteriuria.12
Basic inflammatory parameters and leukocytes. Leukocytes
and CRP were analyzed from blood drawn from an antecubital
vein on admission and between 6 and 8 AM on days 1, 2, 3,
Table 1 Main characteristics in patients with and without poststroke infections
(PSI)
PSI (n 5 24) No PSI (n 5 35) p
Basic characteristics
Age, y 84 (75–86) 72 (61–78) 0.001
Female sex 17 (71) 13 (37) 0.011
Basic parameters, admission
sBP, mm Hg 150 (140–169) 152 (135–167) 0.793
dBP, mm Hg 72 (62–86) 80 (72–95) 0.078
Glucose level, mg/dL 114 (97–146) 113 (98–133) 0.431
Temperature, °C 36.7 (36–37.1) 36.4 (36.1–36.8) 0.166
Heart rate, beats/min 70 (62–93) 73 (67–86) 0.975
Stroke characteristics
Stroke volume, cm3 20.7 (5.0–92.4) 2.7 (1.1–8.9) ,0.001a
Right-sided 10 (48) 10 (33) 0.304
Insular involvement 15 (65) 10 (37) 0.047
NIHSS 11 (9–21) 7 (4–14) 0.003
Thrombolysis 20 (83) 20 (57) 0.034
TOAST classification 0.740
Small vessel 2 (8) 6 (17)
Large vessel 2 (8) 4 (11)
Cardioembolic 11 (46) 13 (37)
Undetermined 9 (38) 12 (34)
Stroke outcome
Poor outcomeb 20 (87) 12 (38) ,0.001
In-hospital mortality 6 (25) 1 (3) 0.015c
3-month mortality 8 (35) 1 (3) 0.003c
Abbreviations: dBP 5 diastolic blood pressure; IQR 5 interquartile range; NIHSS 5 NIH
Stroke Scale; sBP 5 systolic blood pressure.
Data are expressed as median (IQR) or n (%) as appropriate. p Values calculated with
Pearson x2 test or Mann-Whitney U test.
a No control MRI in 6 patients.
bModified Rankin scale score .2 at 3 months.
cp Values calculated with Fisher exact test.
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and 7 after stroke onset. Neutrophils, monocytes, and lympho-
cytes were determined using flow cytometry (CELL-DYN Sap-
phire, Abbott Diagnostics, Abbott Park, IL). Lymphocyte subsets
were enumerated with appropriate monoclonal antibodies and
flow cytometry on admission and between 6 and 8 AM on days
1 and 2 after stroke onset. The following antibodies were used: T
cells (CD31), T-helper cells (CD41), T cytotoxic cells (CD81), B
cells (CD191), natural killer (NK) cells (CD32CD561CD161),
and NK T cells (NKT) (CD31CD561CD161). Two popula-
tions could be distinguished in the NK cells: CD16/56 dim
and CD16/56 bright cells. We excluded 1 patient because of
de novo diagnosis of chronic lymphatic leukemia. Reference val-
ues for the lymphocyte subsets were established on 48 healthy
adults (24 men and 24 women) between 20 and 65 years of age.
Concentrations of CRP (normal ,5 mg/L) were measured using
high-sensitivity turbidimetric immunoassay (Ortho VITROS,
Ortho Clinical Diagnostics, Rochester, NY).
Statistics. We divided the patients into 2 groups: those with and
those without PSI. For the CRP and leukocyte subsets, we per-
formed a separate group-wise analysis at each time point. We
performed a check for normality using the Kolmogorov-
Smirnov test and the Q-Q plot. Continuous data are presented
as median 6 interquartile range (IQR) or as mean 6 95%
confidence interval. The Mann-Whitney U test was applied to
detect differences in continuous not normally distributed data.
The t test was used to detect differences in normally distributed
data. Categorical data were compared using the x2 test or the
Fisher exact test where appropriate. Correlations were
calculated with the Spearman rank correlation coefficient. The
predictive variables (autonomic parameters, CRP, and leukocyte
subsets) were not normally distributed. The data were log-
transformed. Means and differences (ratio) of the means were
calculated using the t test and back-transformed. Data were also
presented after adjustment (analysis of covariance [ANCOVA])
for age and stroke volume, 2 important potential confounders
based on background knowledge and their strong association
with PSI in univariate analysis. For lymphocyte subsets, we
calculated each patient’s percentage change between admission
and day 1 and compared them using t test and ANCOVA.
Sensitivity analysis was performed to determine the impact of
outliers on the association between PSI and CRP and leukocyte
subsets. Outliers were identified using the ROUT method
(Q 5 1%)13 and the boxplot. Analysis was performed with and
without outliers and the results were compared. Analyses were
performed using GraphPad Prism 6.0 and SPSS 22.0 software
package. A p value of ,0.05 was considered significant.
RESULTS Main characteristics. The median time
window between onset of stroke and blood sampling
on admission was 3 hours 2 minutes (IQR 2:28–
4:28). In 12 patients the exact time of onset was
uncertain. Twenty-four (41%) of the ischemic
stroke patients developed an infection, 9 within the
first 48 hours and 15 between 48 hours and 7 days
after onset. Ten patients developed pneumonia, 12
urinary tract infections, and 2 both infections.
In univariate analysis, older age, more severe
stroke, larger infarction volume, insular involve-
ment, treatment with thrombolysis, and female
sex were associated with PSI (table 1). There was
no correlation between age and stroke volume. PSI
was associated with poor outcome, increased
in-hospital mortality, and 3-month mortality
(table 1).
Catecholamines. PSI was associated with increased 24-
hour urinary norepinephrine and epinephrine
concentrations (table 2) after adjustment for
glomerular filtration rate (data not shown). This
association was no longer significant after
adjustment for age and infarction volume (table 2).
Table 2 Autonomic function in patients with and without poststroke infections (PSI)
PSI (n 5 24)a No PSI (n 5 35)a
Unadjusted estimated
ratio of meansb p
Adjusted estimated
ratio of meansc p
Catecholaminesd
uNE, D0, mg/g creat 51 (41–62) 38 (33–44) 1.34 (1.04–1.72) 0.023 1.28 (0.82–2.00) 0.322
uE, D0, mg/g creat 10.8 (8.3–14) 6.8 (5.3–8.8) 1.58 (1.09–2.28) 0.016 1.16 (0.86–1.57) 0.263
Pulse rate variability, D1e
SDNN 26 (20–32) 30 (26–35) 0.84 (0.64–1.11) 0.213 0.98 (0.69–1.37) 0.892
RMSSD 17 (15–20) 23 (19–28) 0.74 (0.58–0.94) 0.013 0.91 (0.64–1.30) 0.586
LF fft, ms2 95 (42–216) 168 (100–283) 0.57 (0.23–1.41) 0.213 1.06 (0.36–3.07) 0.918
LF fft, % 18 (10–34) 24 (19–31) 0.77 (0.40–1.45) 0.394 0.95 (0.50–1.83) 0.882
HF fft, ms2 72 (45–115) 171 (112–260) 0.42 (0.21–0.84) 0.015 0.66 (0.28–1.54) 0.328
HF fft, % 14 (10–19) 24 (19–31) 0.58 (0.39–0.85) 0.007 0.60 (0.38–0.93) 0.022
LF/HF fft 1.3 (0.6–2.8) 1.0 (0.7–1.4) 1.33 (0.66–2.70) 0.411 1.59 (0.69–3.70) 0.262
Abbreviations: HF fft 5 high frequency range fast fourier transform; LF fft 5 low frequency range fast fourier transform; RMSSD 5 root mean square
differences of successive RR intervals; SDNN 5 SD of a series of RR intervals; uE 5 urinary epinephrine; uNE 5 urinary norepinephrine.
a Values are expressed as estimated means (95% confidence interval).
b, cValues can be interpreted as the ratio of the estimated mean in the PSI group to the estimated mean in the no PSI group and were obtained by back-
transforming the results from a log-transformed t testb or analysis of covariancec (adjusted for age and stroke volume).
dN 5 52.
eN 5 38.
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Pulse rate variability parameters. SDNN, LF, and LF/
HF on admission were similar in patients with and
without infections after stroke onset. Decreased
RMSSD and HF were associated with PSI (table 2).
After adjustment for age and infarction volume, the
HF (%) remained significant (p 5 0.022).
CRP and leukocyte subsets. PSI was associated with an
increased CRP, increased neutrophil and monocyte
counts, and a decreased lymphocyte count (figure 1).
These associations remained after exclusion of out-
liers. After adjustment for age and stroke volume,
increased CRP on days 2 and 3 and neutrophilic
count on days 1, 2, and 3 remained significant
(figure 1).
The group developing infections had an increased
number of NK cells on admission (p 5 0.001) and
after adjustment for age and stroke volume (p 5
0.039) (figure 2). There was no correlation between
NK cells on admission and either age or stroke vol-
ume in patients with and without PSI (figure 3). On
day 1, patients who developed infections had a
decreased number of T cells (p 5 0.009) and
T-helper cells (p 5 0.008) (figure 2). This finding
did not remain significant after adjustment for age
and stroke volume. There was no association between
PSI and the number of B cells, NKT, or cytotoxic
T cells (data not shown). PSI was associated with a
decrease varying between 22% and 40% in all lym-
phocyte subsets from admission to day 1 after stroke
onset. This decrease was not demonstrated in patients
without PSI, who showed a mean increase varying
between 2% and 23% (all p , 0.005). This finding
remained significant after adjustment for age and
stroke volume (all p , 0.05) (figure 4).
Patients with increased NK cells (dichotomized
over the mean) had larger infarction volumes (19.5
mL, IQR 4.3–5.5 vs 3.14 mL, IQR 0.8–10.9; p 5
0.018). Further analysis revealed that 98% of NK
cells on admission and days 1 and 2 were CD16/
CD56 dim cells.
Exclusion of outliers in the lymphocyte subsets
did not change the results.
DISCUSSION We report that an increase in circulat-
ing NK cells within the first hours after stroke
occurred in patients who developed infections. NK
cells are part of the innate immune system and medi-
ate rapid responses to various antigens as a first-line
defense against infected or transformed cells. NK
cells control CNS inflammation by killing
proinflammatory microglial cells, which are
activated within minutes of ischemia onset.14–16
Extensive infiltration of NK cells has been described
in ischemic lesions of the human brain, and it has
been suggested that these cells might exert a
detrimental effect on infarct volume and stroke
outcome, particularly in the early poststroke
phase.17 An early rise in circulating NK cells has not
Figure 1 Time course of C-reactive protein (CRP) and leukocyte subsets in
patients with and without poststroke infections (PSI)
Values are expressed as means6 95% confidence interval. Solid lines show the time course
of unadjusted means, dashed lines show the means assuming a 74-year-old with a stroke
volume of 5 mL. The dotted line depicts the mean value in healthy individuals. *p , 0.05,
**p, 0.01, ***p, 0.005, PSI vs no PSI, unadjusted/adjusted, t test (unadjusted), analysis of
covariance (adjusted). NCRP (PSI): admission (adm)5 24, day 15 23, day 25 16, day 35 18,
day 7 5 19; NCRP (no PSI): adm 5 35, day 1 5 34, day 2 5 26, day 3 5 26, day 7 5 22;
Nleukocyte subsets (PSI): adm 5 24, day 1 5 21, day 2 5 20, day 3 5 19, day 7 5 17; Nleukocyte
subsets (no PSI): adm 5 34, day 1 5 32, day 2 5 29, day 3 5 30, day 7 5 22.
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been described before in studies investigating
lymphocyte subsets in acute ischemic stroke.2–5 This
may be explained by earlier inclusion in our study.
Median time between stroke onset and blood
sampling was 3 hours. One of the previous studies
also performed early blood sampling with a median
time window of 3 hours and showed a trend to
increased NK cells in patients who developed an
infection.4
The transient increase in NK cells in patients
with PSI was followed by a drop in all circulating
lymphocyte subsets. This supports previous studies
showing an association between PSI and reduced
lymphocytes,2,4,5 especially T cells3–5 and T-helper
cells.2–5
In stroke patients developing infections, we found
decreased RMSSD and HF component in PRV and
increased 24-hour urinary levels of both norepinephrine
and epinephrine. After age and volume adjustment, on-
ly decreased HF power remained significant. This
might be suggestive of a sympathovagal imbalance with
sympathetic overweight preceding the infections. This
supports earlier studies that showed elevated plasma
metanephrine and normetanephrine levels7,18 and
increased urinary norepinephrine levels in association
with PSI.3,19 However, Günther et al. found that
increased HF power, reduced LF power, and decreased
LF/HF ratio, suggestive of parasympathetic overactiv-
ity, predicted subacute infection in acute ischemic
stroke.6 Urinary catecholamines do not directly reflect
end-organ sympathetic activity in the spleen or lymph
nodi, which are important organs in the mobilization of
leukocytes. However, urinary concentrations of epi-
nephrine and norepinephrine correlate with circulating
concentrations in the blood, which are a measure of
sympathoadrenal medullary activity,20 reflecting global
sympathetic activity.
Similar to the hyperacute phase of stroke, acute
mental and cold stress has been associated with a
rapid increase in lymphocytes, especially NK cells,
followed by a decrease in lymphocytes if stress per-
sists.21,22 The increase in circulating lymphocytes
and particularly in NK cells reflects a mobilization
of lymphocytes into the blood from the marginal
blood pool. Norepinephrine and epinephrine released
during stress reduce NK cell adhesion to the vascular
endothelium via b-adrenergic receptors on their sur-
face, resulting in an increase in the number of NK
cells in peripheral blood.23 Activation of the sympa-
thetic nervous system increases blood pressure and
vascular shear forces, which may also promote the
release of marginated cells into the bloodstream.24
The b-adrenergic antagonists nadolol and proprano-
lol could prevent the increase in NK cells in rats with
acute social stress.24 The subsequent immune depres-
sion probably reflects a complex process including cell
redistribution and catecholamine-mediated increased
cell death. Lymphocytes migrate to the ischemic brain
lesion17 and to sites of origin such as bone marrow
and spleen.25,26 Chronic a-adrenergic stimulation
increased lymphocyte apoptosis in the spleen and
lymph nodes and decreased circulating B and T cells
in rats.27 Administration of the b-adrenergic blocker
propranolol prevented the decrease in all peripheral
blood lymphocyte subsets in a mouse model of focal
cerebral ischemia.7
Our results should be interpreted with caution
because of the small number of patients and the pos-
sible influence of untested confounding factors.
Therefore, larger studies are required to investigate
whether a high NK cell count within the first hours
Figure 2 Time course of lymphocyte subsets in patients with and without
poststroke infections (PSI)
Values are expressed as means6 95% confidence interval. Solid lines show the time course
of unadjusted means, dashed lines show the means assuming a 74-year-old with a stroke
volume of 5 mL. The dotted line depicts the mean value in healthy individuals. *p , 0.05,
**p, 0.01, ***p5 0.001, PSI vs no PSI, unadjusted/adjusted, t test (unadjusted), analysis of
covariance (adjusted). N (PSI): admission (adm) 5 23, day 1 5 21, day 2 5 22; N (no PSI):
adm 5 31, day 1 5 32, day 2 5 30. NK 5 natural killer.
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after ischemic stroke might serve as a biomarker for
identifying patients at risk for infections and to fur-
ther elaborate on the interplay between the auto-
nomic nervous system and lymphocyte subsets in
acute ischemic stroke.
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